Pembrolizumab plus chemotherapy with or without bevacizumab could be a new standard of care for first-line therapy in metastatic cervical cancer.
Your search for bevacizumab returned 9 results
There was no improvement in overall survival with bevacizumab.
Researchers investigated the association between nonalcoholic fatty liver disease and early-onset colorectal cancer according to anatomical site.
Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.
High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.
The approval was based on data from the phase 3 KEYNOTE-826 trial.
The checkpoint inhibitor cemiplimab improved survival in patients with recurrent/metastatic cervical carcinoma compared with single-agent chemotherapy.
Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.
Study shows reductions in intraocular pressures and antiglaucoma medication use.